Skip to main content
Yung Lyou, MD, Oncology, Fullerton, CA

YungLyouMDPhD

Oncology • Fullerton, CA

Medical oncologist and phase 1 clinical trials lead

Join to view full profile

Dr. Lyou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lyou's full profile

Already have an account?

  • Office

    2151 N Harbor Blvd
    Fullerton, CA 92835
    Phone+1 714-446-5900

Summary

  • Dr. Yung Lyou is an oncologist and clinical researcher at Providence St. Jude Cross Cancer Institute with numerous peer reviewed abstracts and publications. He is also the Oncology Phase 1 clinical trials program lead. Prior to joining Providence St. Jude he was an assistant clinical professor at City of Hope Comprehensive Cancer Center. He is an expert in genitourinary (prostate, bladder, kidney), lung, and gastrointestinal cancers.

Education & Training

  • University of California (Irvine)
    University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2014 - 2018
  • University of California (Irvine)
    University of California (Irvine)Residency, Internal Medicine, 2012 - 2015
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Orbital Metastases from Breast Cancer with BRCA2 Mutation: A Case Report and Literature Review  
    Yung Lyou, Erin Lin, Case Reports in Oncology

Press Mentions

  • Breast Cancer: Researchers Say It's OK to Pause Long-Term Treatment for Pregnancy
    Breast Cancer: Researchers Say It's OK to Pause Long-Term Treatment for PregnancyDecember 13th, 2022
  • Prostate Cancer Care Rebounding After COVID-19 Disruption
    Prostate Cancer Care Rebounding After COVID-19 DisruptionSeptember 1st, 2020
  • Loss, Mutation of NCOR2 Likely Fuels Prostate Cancer Progression, Resistance
    Loss, Mutation of NCOR2 Likely Fuels Prostate Cancer Progression, ResistanceDecember 28th, 2021
  • Join now to see all

Other Languages

  • Korean

Dr. Yung Lyou, Dr. Yung Lyou, MD, Dr. Y Lyou